{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:24:22Z","timestamp":1793384662604,"version":"4.5.0"},"reference-count":139,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T00:00:00Z","timestamp":1403654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"name":"Office of Research and Development, Department of Veterans Affairs","award":["1BX001729"],"award-info":[{"award-number":["1BX001729"]}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["GRNT12060205"],"award-info":[{"award-number":["GRNT12060205"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Chronic inflammatory diseases are associated with accelerated atherosclerosis and increased risk of cardiovascular diseases (CVD). As the pathogenesis of atherosclerosis is increasingly recognized as an inflammatory process, similarities between atherosclerosis and systemic inflammatory diseases such as rheumatoid arthritis, inflammatory bowel diseases, lupus, psoriasis, spondyloarthritis and others have become a topic of interest. Endothelial dysfunction represents a key step in the initiation and maintenance of atherosclerosis and may serve as a marker for future risk of cardiovascular events. Patients with chronic inflammatory diseases manifest endothelial dysfunction, often early in the course of the disease. Therefore, mechanisms linking systemic inflammatory diseases and atherosclerosis may be best understood at the level of the endothelium. Multiple factors, including circulating inflammatory cytokines, TNF-\u03b1 (tumor necrosis factor-\u03b1), reactive oxygen species, oxidized LDL (low density lipoprotein), autoantibodies and traditional risk factors directly and indirectly activate endothelial cells, leading to impaired vascular relaxation, increased leukocyte adhesion, increased endothelial permeability and generation of a pro-thrombotic state. Pharmacologic agents directed against TNF-\u03b1-mediated inflammation may decrease the risk of endothelial dysfunction and cardiovascular disease in these patients. Understanding the precise mechanisms driving endothelial dysfunction in patients with systemic inflammatory diseases may help elucidate the pathogenesis of atherosclerosis in the general population.<\/jats:p>","DOI":"10.3390\/ijms150711324","type":"journal-article","created":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T02:28:30Z","timestamp":1403749710000},"page":"11324-11349","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":428,"title":["Endothelial Dysfunction in Chronic Inflammatory Diseases"],"prefix":"10.3390","volume":"15","author":[{"suffix":"III","given":"Curtis","family":"Steyers","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Francis","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA"},{"name":"Department of Internal Medicine, Veterans Affair Medical Center, Iowa City, IA 52242, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2014,6,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2012.05.013","article-title":"Endothelial dysfunction in rheumatic autoimmune diseases","volume":"224","author":"Murdaca","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Prati, C., Demougeot, C., Guillot, X., Godfrin-Valnet, M., and Wendling, D. (2014). Endothelial dysfunction in joint disease. Jt. Bone Spine.","DOI":"10.1016\/j.jbspin.2014.01.014"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1177\/0961203313493031","article-title":"Premature coronary heart disease in systemic lupus erythematosus: What risk factors do we understand?","volume":"22","author":"Nikpour","year":"2013","journal-title":"Lupus"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.semarthrit.2004.07.010","article-title":"Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis","volume":"34","author":"Peters","year":"2004","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jbspin.2010.05.001","article-title":"Spondyloarthropathies: an independent cardiovascular risk factor?","volume":"77","author":"Mathieu","year":"2010","journal-title":"Jt. Bone Spine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cgh.2013.08.023","article-title":"Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: A systematic review and meta-analysis","volume":"12","author":"Singh","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/art.1780250602","article-title":"A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death","volume":"25","author":"Rosner","year":"1982","journal-title":"Arthritis Rheum."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"III27","DOI":"10.1161\/01.CIR.0000131515.03336.f8","article-title":"Role of endothelial dysfunction in atherosclerosis","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","article-title":"Endothelial Dysfunction: A Marker of Atherosclerotic Risk","volume":"23","author":"Bonetti","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1046\/j.1365-2281.2000.00281.x","article-title":"Evaluation of endothelium-dependent vasodilation in the human peripheral circulation","volume":"20","author":"Lind","year":"2000","journal-title":"Clin. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: Testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ghiadoni, L., Salvetti, M., Muiesan, M.L., and Taddei, S. (2014). Evaluation of endothelial function by flow mediated dilation: Methodological issues and clinical importance. High Blood Press Cardiovasc. Prev., in press.","DOI":"10.1007\/s40292-014-0047-2"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/0735-1097(95)00327-4","article-title":"Close relation of endothelial function in the human coronary and peripheral circulations","volume":"26","author":"Anderson","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0735-1097(03)00994-X","article-title":"The clinical implications of endothelial dysfunction","volume":"42","author":"Widlansky","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10554-010-9616-1","article-title":"Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: A meta-analysis","volume":"26","author":"Inaba","year":"2010","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1549-8719.2011.00129.x","article-title":"Non-invasive assessment of skin microvascular function in humans: An insight into methods","volume":"19","author":"Roustit","year":"2012","journal-title":"Microcirculation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/eurheartj\/ehp205","article-title":"Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease","volume":"30","author":"Mason","year":"2009","journal-title":"Eur. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(97)09032-6","article-title":"Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men","volume":"351","author":"Ridker","year":"1998","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1161\/01.CIR.96.12.4219","article-title":"Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study","volume":"96","author":"Hwang","year":"1997","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/157340310791162659","article-title":"The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease","volume":"6","author":"Sibal","year":"2010","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.phrs.2009.07.001","article-title":"Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality--an update on patient populations with a wide range of cardiovascular risk","volume":"60","author":"Boger","year":"2009","journal-title":"Pharmacol. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMoa022287","article-title":"Circulating endothelial progenitor cells, vascular function, and cardiovascular risk","volume":"348","author":"Hill","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1038\/jid.2013.149","article-title":"Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis","volume":"133","author":"Samarasekera","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ahj.2013.07.010","article-title":"Rheumatoid arthritis and cardiovascular disease","volume":"166","author":"Crowson","year":"2013","journal-title":"Am. Heart J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1136\/ard.2005.050377","article-title":"Patterns of cardiovascular risk in rheumatoid arthritis","volume":"65","author":"Solomon","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies","volume":"59","author":"Choi","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/art.24537","article-title":"Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses\u2019 health study","volume":"61","author":"Hak","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/aje\/kws130","article-title":"Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus","volume":"176","author":"Magder","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/art.21955","article-title":"Mortality in systemic lupus erythematosus","volume":"54","author":"Bernatsky","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/acr.20364","article-title":"Cardiovascular profile in ankylosing spondylitis: A systematic review and meta-analysis","volume":"63","author":"Mathieu","year":"2011","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/ard.2009.110593","article-title":"Ankylosing spondylitis: A risk factor for myocardial infarction?","volume":"69","author":"Peters","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.crohns.2013.09.021","article-title":"Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: A meta-analysis of observational studies","volume":"8","author":"Fumery","year":"2014","journal-title":"J. Crohns Colitis"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1572-0241.2006.01018.x","article-title":"Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: Results from a systematic review and meta-analysis","volume":"102","author":"Dorn","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/01.ATV.0000033516.73864.4E","article-title":"Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis","volume":"22","author":"Bergholm","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.semarthrit.2011.08.003","article-title":"Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: An observational study","volume":"41","author":"Guin","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_38","first-page":"398","article-title":"Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: A multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity","volume":"35","author":"Kerekes","year":"2008","journal-title":"J. Rheumatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/ard.2003.007740","article-title":"Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity","volume":"63","author":"Vaudo","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0021-9150(03)00281-8","article-title":"Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity","volume":"170","author":"Pistrosch","year":"2003","journal-title":"Atherosclerosis"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/03009740802279709","article-title":"Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis","volume":"38","author":"Syngle","year":"2009","journal-title":"Scand. J. Rheumatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.atherosclerosis.2006.05.034","article-title":"Inflammatory suppression rapidly attenuates microvascular dysfunction in rheumatoid arthritis","volume":"192","author":"Datta","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/rheumatology\/ken386","article-title":"C-reactive protein: The underlying cause of microvascular dysfunction in rheumatoid arthritis","volume":"47","author":"Galarraga","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"R158","DOI":"10.1186\/ar3116","article-title":"Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness","volume":"12","author":"Sodergren","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2362.2011.02607.x","article-title":"An observational study of endothelial function in early arthritis","volume":"42","author":"Foster","year":"2012","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/rheumatology\/ker275","article-title":"Vascular function and morphology in rheumatoid arthritis: A systematic review","volume":"50","author":"Sandoo","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/rheumatology\/36.2.164","article-title":"A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis","volume":"36","author":"Littler","year":"1997","journal-title":"Br. J. Rheumatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/03009740701406460","article-title":"Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis","volume":"36","author":"Klimiuk","year":"2007","journal-title":"Scand. J. Rheumatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"R634","DOI":"10.1186\/ar1717","article-title":"Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis","volume":"7","author":"Dessein","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/030097498442415","article-title":"Soluble cell adhesion molecules\u2014P-selectin and ICAM-1, and disease activity in patients receiving sulphasalazine for active rheumatoid arthritis","volume":"27","author":"Veale","year":"1998","journal-title":"Scand. J. Rheumatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00296-007-0397-3","article-title":"Microvascular dysfunction in rheumatoid arthritis assessed by laser Doppler anemometry: Relationship to soluble adhesion molecules and extraarticular manifestations","volume":"28","author":"Meyer","year":"2007","journal-title":"Rheumatol. Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/HYPERTENSIONAHA.110.168245","article-title":"Role of asymmetrical dimethylarginine in inflammation-induced endothelial dysfunction in human atherosclerosis","volume":"58","author":"Antoniades","year":"2011","journal-title":"Hypertension"},{"key":"ref_53","first-page":"292","article-title":"Brachial endothelial function is impaired in patients with systemic lupus erythematosus","volume":"29","author":"Lima","year":"2002","journal-title":"J. Rheumatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jaut.2006.09.008","article-title":"Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients","volume":"27","author":"Kiss","year":"2006","journal-title":"J. Autoimmun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.CIR.0000136807.78534.50","article-title":"Systemic lupus erythematosus: An independent risk factor for endothelial dysfunction in women","volume":"110","author":"Bodill","year":"2004","journal-title":"Circulation"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/0961203306074842","article-title":"Impaired endothelial function in systemic lupus erythematosus","volume":"16","author":"Piper","year":"2007","journal-title":"Lupus"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1161\/01.ATV.0000238351.82900.7f","article-title":"Microcirculatory hemodynamics and endothelial dysfunction in systemic lupus erythematosus","volume":"26","author":"Wright","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/03009740802007514","article-title":"Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus","volume":"37","author":"Svenungsson","year":"2008","journal-title":"Scand. J. Rheumatol."},{"key":"ref_59","first-page":"5","article-title":"Increased levels of intercellular adhesion molecule-1 in the serum of patients with systemic lupus erythematosus","volume":"12","author":"Sfikakis","year":"1994","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02231684","article-title":"Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with systemic lupus erythematosus","volume":"15","author":"Tulek","year":"1996","journal-title":"Clin. Rheumatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/clin.1993.1098","article-title":"Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"68","author":"Machold","year":"1993","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/rheumatology\/33.12.1112","article-title":"Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis","volume":"33","author":"Janssen","year":"1994","journal-title":"Br. J. Rheumatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2249.1994.tb06107.x","article-title":"Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study","volume":"97","author":"Spronk","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00296-001-0159-6","article-title":"Correlation of serum levels of soluble intercellular adhesion molecule-1 with disease activity in systemic lupus erythematosus","volume":"21","author":"Sari","year":"2001","journal-title":"Rheumatol. Int."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/rheumatology\/kei145","article-title":"Impaired endothelial function in patients with ankylosing spondylitis","volume":"45","author":"Sari","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/art.22530","article-title":"Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors","volume":"57","author":"Llorca","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3899\/jrheum.100668","article-title":"Assessment of subclinical vascular disease associated with ankylosing spondylitis","volume":"38","author":"Bodnar","year":"2011","journal-title":"J. Rheumatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/BF01451047","article-title":"Soluble intercellular adhesion molecule 1 in spondylarthropathies","volume":"17","author":"Wendling","year":"1998","journal-title":"Clin. Rheumatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jbspin.2009.07.005","article-title":"Assessment of soluble cell adhesion molecules and soluble CD40 ligand levels in ankylosing spondylitis","volume":"77","author":"Sari","year":"2010","journal-title":"Jt. Bone Spine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jbspin.2010.05.009","article-title":"Increased production of asymmetric dimethylarginine (ADMA) in ankylosing spondylitis: association with other clinical and laboratory parameters","volume":"78","author":"Gesztelyi","year":"2011","journal-title":"Jt. Bone Spine"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10067-010-1589-x","article-title":"Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: A cross-sectional study","volume":"30","author":"Erre","year":"2011","journal-title":"Clin. Rheumatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/138161282004140213123852","article-title":"Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: A systematic review","volume":"20","author":"Brezinski","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2008.02936.x","article-title":"Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis","volume":"23","author":"Balci","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.clinbiochem.2011.06.007","article-title":"Vascular endothelial function assessed by a noninvasive ultrasound method and serum asymmetric dimethylarginine concentrations in mild-to-moderate plaque-type psoriatic patients","volume":"44","author":"Usta","year":"2011","journal-title":"Clin. Biochem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2133.2010.10031.x","article-title":"A prospective case-controlled cohort study of endothelial function in patients with moderate to severe psoriasis","volume":"164","author":"Ranawaka","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0016-5085(03)00699-1","article-title":"Acquired microvascular dysfunction in inflammatory bowel disease: Loss of nitric oxide-mediated vasodilation","volume":"125","author":"Hatoum","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.MIB.0000217764.88980.74","article-title":"Endothelial dysfunction in patients with ulcerative colitis","volume":"12","author":"Kocaman","year":"2006","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.1016\/j.crohns.2013.02.001","article-title":"Endothelial function and cardiovascular risk in active inflammatory bowel diseases","volume":"7","author":"Principi","year":"2013","journal-title":"J. Crohns Colitis"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jpeds.2012.03.043","article-title":"Premature subclinical atherosclerosis in pediatric inflammatory bowel disease","volume":"161","author":"Aloi","year":"2012","journal-title":"J. Pediatr."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nprot.2007.173","article-title":"Collagen-induced arthritis","volume":"2","author":"Brand","year":"2007","journal-title":"Nat. Protoc."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/ATVBAHA.113.301490","article-title":"Endothelial dysfunction in rheumatoid arthritis: The role of monocyte chemotactic protein-1-induced protein","volume":"33","author":"He","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1136\/annrheumdis-2013-205124.6","article-title":"A1.6 Vascular adhesion molecule VCAM-1 overexpression in collagen induced arthritis: A model for rheumatoid arthritis vascular dysfunction","volume":"73","author":"Denys","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/art.21891","article-title":"Endothelial dysfunction in rat adjuvant-induced arthritis: Vascular superoxide production by NAD(P)H oxidase and uncoupled endothelial nitric oxide synthase","volume":"54","author":"Haruna","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_84","first-page":"122","article-title":"Alterations of the endothelial function of isolated aortae in rats with adjuvant arthritis","volume":"311","author":"Fang","year":"1991","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000358367","article-title":"Endothelial dysfunction in an ovine model of collagen-induced arthritis","volume":"51","author":"Dooley","year":"2014","journal-title":"J. Vasc. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"L452","DOI":"10.1152\/ajplung.00378.2002","article-title":"TNF-alpha induces a decrease in eNOS promoter activity","volume":"286","author":"Neumann","year":"2004","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pharmthera.2010.05.002","article-title":"TNFalpha in atherosclerosis, myocardial ischemia\/reperfusion and heart failure","volume":"127","author":"Kleinbongard","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/jcb.21845","article-title":"NF-kappaB, but not p38 MAP kinase, is required for TNF-alpha-induced expression of cell adhesion molecules in endothelial cells","volume":"105","author":"Rajan","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbrc.2009.05.046","article-title":"Influence of TNF-alpha and biomechanical stress on endothelial anti- and prothrombotic genes","volume":"385","author":"Bergh","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_90","first-page":"H2535","article-title":"Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation","volume":"266","author":"Wang","year":"1994","journal-title":"Am. J. Physiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/01.ATV.0000065195.22904.FA","article-title":"Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans","volume":"23","author":"Chia","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/01.CIR.102.9.994","article-title":"Acute systemic inflammation impairs endothelium-dependent dilatation in humans","volume":"102","author":"Hingorani","year":"2000","journal-title":"Circulation"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2004.11.016","article-title":"Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice","volume":"180","author":"Ohta","year":"2005","journal-title":"Atherosclerosis"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3109\/10715762.2012.727991","article-title":"Oxidative stress as a potential biomarker for determining disease activity in patients with rheumatoid arthritis","volume":"46","author":"Kundu","year":"2012","journal-title":"Free Radic. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.0000229685.37402.80","article-title":"Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome","volume":"99","author":"Picchi","year":"2006","journal-title":"Circ. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"459","DOI":"10.18388\/abp.2004_3584","article-title":"Endothelial NADH\/NADPH-dependent enzymatic sources of superoxide production: Relationship to endothelial dysfunction","volume":"51","author":"Kalinowski","year":"2004","journal-title":"Acta Biochim. Pol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.freeradbiomed.2010.12.018","article-title":"Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders","volume":"50","author":"Gielis","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/CS20030379","article-title":"Strategies to reduce oxidative stress in cardiovascular disease","volume":"106","author":"Hamilton","year":"2004","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/01.ATV.20.6.1430","article-title":"Interactions of oxidants with vascular signaling Systems","volume":"20","author":"Wolin","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1186\/ar3424","article-title":"Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis","volume":"13","author":"Biniecka","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1253\/circj.CJ-09-0274","article-title":"Rheumatoid arthritis: Model of systemic inflammation driving atherosclerosis","volume":"73","author":"Ku","year":"2009","journal-title":"Circ. J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5","article-title":"Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: Possible contribution of phospholipase A2 to this atherogenic profile","volume":"44","author":"Paredes","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_103","first-page":"297","article-title":"Apoptosis and proliferation of endothelial cells in early atherosclerotic lesions: possible role of oxidised LDL","volume":"12","author":"Norata","year":"2002","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1475-097X.2008.00825.x","article-title":"Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia","volume":"28","author":"Deneva","year":"2008","journal-title":"Clin. Physiol. Funct. Imaging"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00441-012-1437-1","article-title":"Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis","volume":"349","author":"Stancu","year":"2012","journal-title":"Cell. Tissue Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0961203310382429","article-title":"The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?","volume":"20","author":"Narshi","year":"2011","journal-title":"Lupus"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"57","DOI":"10.20452\/pamw.306","article-title":"Vasculopathy and vasculitis in systemic lupus erythematosus","volume":"118","author":"Cieslik","year":"2008","journal-title":"Pol. Arch. Med. Wewn."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/rheumatology\/keh109","article-title":"Association of biological markers of activity of systemic lupus erythematosus with levels of anti-oxidized low-density lipoprotein antibodies","volume":"43","author":"Tinahones","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jama.2009.1346","article-title":"Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome","volume":"302","author":"Charakida","year":"2009","journal-title":"JAMA"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/03009742.2012.656698","article-title":"Endothelial function improves within 6 weeks of treatment with methotrexate or methotrexate in combination with a TNF-alpha inhibitor in rheumatoid arthritis patients","volume":"41","author":"Hjeltnes","year":"2012","journal-title":"Scand. J. Rheumatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.clpt.2006.05.011","article-title":"Intravascular tumor necrosis factor alpha blockade reverses endothelial dysfunction in rheumatoid arthritis","volume":"80","author":"Cardillo","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00296-006-0147-y","article-title":"Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis","volume":"26","author":"Bilsborough","year":"2006","journal-title":"Rheumatol. Int."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","article-title":"Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis","volume":"106","author":"Hurlimann","year":"2002","journal-title":"Circulation"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/art.20407","article-title":"Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody","volume":"51","author":"Testa","year":"2004","journal-title":"Arthritis Rheum."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/03009740802363768","article-title":"Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients","volume":"38","author":"Sidiropoulos","year":"2009","journal-title":"Scand. J. Rheumatol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10067-007-0803-y","article-title":"TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis","volume":"27","author":"Bosello","year":"2008","journal-title":"Clin. Rheumatol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/s10165-007-0605-8","article-title":"Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis","volume":"17","author":"Komai","year":"2007","journal-title":"Mod. Rheumatol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/ard.2007.086777","article-title":"Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockade","volume":"68","author":"Peters","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10067-010-1402-x","article-title":"Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-alpha blockade","volume":"29","author":"Syngle","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijcard.2011.06.112","article-title":"Anti-tumor necrosis factor alpha treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis","volume":"151","author":"Avgerinou","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sj.clpt.6100229","article-title":"Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn\u2019s disease","volume":"83","author":"Schinzari","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3899\/jrheum.090417","article-title":"Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy","volume":"37","author":"Galarraga","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10067-009-1095-1","article-title":"Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis","volume":"28","author":"Kerekes","year":"2009","journal-title":"Clin. Rheumatol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1024\/0301-1526\/a000220","article-title":"Carotid artery intima-media thickness and brachial artery flow-mediated vasodilatation in patients with rheumatoid arthritis","volume":"41","author":"Veselinovic","year":"2012","journal-title":"VASA"},{"key":"ref_125","first-page":"1810","article-title":"Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized study","volume":"34","author":"Hafstrom","year":"2007","journal-title":"J. Rheumatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jacc.2007.04.076","article-title":"Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis","volume":"50","author":"Booth","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_127","first-page":"2095","article-title":"Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis","volume":"32","author":"Tikiz","year":"2005","journal-title":"J. Rheumatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jacc.2004.11.006","article-title":"Simvastatin improves endothelial function in patients with rheumatoid arthritis","volume":"45","author":"Hermann","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/kem186","article-title":"Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: An 8 weeks controlled trial","volume":"46","author":"Ferreira","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/03009740903079321","article-title":"Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis","volume":"38","author":"Klimiuk","year":"2009","journal-title":"Scand. J. Rheumatol."},{"key":"ref_131","first-page":"373","article-title":"Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis","volume":"24","author":"Martin","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jbspin.2010.02.040","article-title":"Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: A systematic literature review","volume":"78","author":"Fautrel","year":"2011","journal-title":"Jt. Bone Spine"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1161\/01.ATV.0000038754.39483.CD","article-title":"Unraveling pleiotropic effects of statins on plaque rupture","volume":"22","author":"Palinski","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_135","first-page":"2024","article-title":"Antiinflammatory effect of simvastatin in patients with rheumatoid arthritis","volume":"29","author":"Kanda","year":"2002","journal-title":"J. Rheumatol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): Double-blind, randomised placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"key":"ref_137","first-page":"964","article-title":"Beneficial action of statins in patients with rheumatoid arthritis in a large observational cohort","volume":"34","author":"Okamoto","year":"2007","journal-title":"J. Rheumatol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3899\/jrheum.110318","article-title":"Effectiveness of statins on total cholesterol and cardiovascular disease and all-cause mortality in osteoarthritis and rheumatoid arthritis","volume":"39","author":"Sheng","year":"2012","journal-title":"J. Rheumatol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/art.34524","article-title":"Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease","volume":"64","author":"Semb","year":"2012","journal-title":"Arthritis Rheum."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/15\/7\/11324\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:12:54Z","timestamp":1760217174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/15\/7\/11324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,25]]},"references-count":139,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7]]}},"alternative-id":["ijms150711324"],"URL":"https:\/\/doi.org\/10.3390\/ijms150711324","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,25]]}}}